Zenotech Laboratories Limited (BOM:532039)

Zenotech Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	56.13	82.99	115.85	221.76	-12.15
Depreciation & Amortization	69.6	70.85	71.73	69.74	64.56
Loss (Gain) From Sale of Assets	-	0.44	-0.39	-	-
Other Operating Activities	-1.91	8.08	14.51	-122.37	10.86
Change in Accounts Receivable	-42.05	0.74	6.05	-1.25	-19.46
Change in Inventory	8.4	-8.4	0.61	0.01	0.32
Change in Accounts Payable	-7.51	-1.73	14.31	2.22	-23.9
Change in Other Net Operating Assets	12.23	-34.74	-16.02	6.57	37.18
Operating Cash Flow	94.88	118.23	206.64	176.67	57.41
Operating Cash Flow Growth	-19.74%	-42.79%	16.96%	207.74%	-49.55%
Capital Expenditures	-38.63	-42.34	-62.32	-19.38	-49.12
Sale of Property, Plant & Equipment	-	0.04	0.39	-	-
Other Investing Activities	191.52	-169.25	3.69	0.99	0.94
Investing Cash Flow	152.89	-211.55	-58.24	-18.39	-48.18
Long-Term Debt Issued	-	-	-	-	20
Total Debt Issued	-	-	-	-	20
Long-Term Debt Repaid	-	-	-60	-146.56	-
Total Debt Repaid	-	-	-60	-146.56	-
Net Debt Issued (Repaid)	-	-	-60	-146.56	20
Other Financing Activities	-	-	-1.12	-12.15	-15.48
Financing Cash Flow	-	-	-61.12	-158.71	4.53
Foreign Exchange Rate Adjustments	-0.18	0.05	-	-	-
Net Cash Flow	247.59	-93.27	87.28	-0.43	13.76
Free Cash Flow	56.25	75.89	144.33	157.3	8.3
Free Cash Flow Growth	-25.88%	-47.42%	-8.25%	1796.31%	-
Free Cash Flow Margin	14.39%	20.62%	37.00%	47.74%	4.27%
Free Cash Flow Per Share	0.92	1.24	2.37	2.58	0.14
Cash Interest Paid	-	-	1.12	12.15	15.48
Cash Income Tax Paid	19.39	10.73	11.9	10.04	1.17
Levered Free Cash Flow	39.51	48.04	106.07	116.72	-15.27
Unlevered Free Cash Flow	39.51	48.04	106.77	124.32	-5.6
Change in Working Capital	-28.94	-44.13	4.94	7.55	-5.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.